Results 251 to 260 of about 44,003 (309)

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

DeepSeek for healthcare: do no harm? [PDF]

open access: yesAI Ethics
Anibal J   +8 more
europepmc   +1 more source

Why does AI hinder democratization? [PDF]

open access: yesProc Natl Acad Sci U S A
Chu CYC, Chang JJ, Lin CC.
europepmc   +1 more source

The impact on undergraduate students. [PDF]

open access: yesElife
Tian R   +5 more
europepmc   +1 more source

Estimating mortality in conflict settings: expert perspectives on methods, barriers, and ethical challenges. [PDF]

open access: yesBMC Public Health
Maddah D   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy